| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 5, 2007
Accepted on March 3, 2008
University of Würzburg, Institute for Virology and Immunobiology, Versbacher Strasse 7, 97078 Würzburg, Germany; University of Göttingen, Medical School, Department of Cellular and Molecular Immunology, Humboldtallee 34, 37073 Göttingen, Germany; University of Würzburg, Department of Internal Medicine I, Endocrine and Diabetes Unit, Josef-Schneider-Strasse 2, 97080 Würzburg, Germany
* To whom correspondence should be addressed. E-mail: hreichardt{at}med.uni-goettingen.de.
Currently gene disruption by homologous recombination in embryonic stem cells is only feasible in mice. To circumvent this problem, we silenced mineralocorticoid receptor (MR) expression by RNA interference in knock-down rats generated through lentiviral transgenesis. Analysis of the F1 progeny at three weeks of age revealed strongly decreased MR levels. This was specific for the targeted gene and related to the abundance of the siRNA. Reminiscent of MR knock-out mice, the transgenic rats showed a reduced body weight, elevated serum aldosterone levels, increased plasma renin activity and altered expression of MR target genes. Some of these effects correlated with the degree to which MR mRNA expression was reduced. Whilst disruption of the MR by gene targeting in mice leads to postnatal death, our strategy also allowed obtaining adult knock-down rats with defects in hormone and electrolyte homeostasis resembling pseudohypoaldosteronism. In conclusion, this is the first example of a human disease model based on RNA interference in rats.
NURSA Molecule Pages Link:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |